Page last updated: 2024-08-21

podophyllotoxin and Hodgkin Disease

podophyllotoxin has been researched along with Hodgkin Disease in 69 studies

Research

Studies (69)

Timeframe	Studies, this research(%)	All Research%
pre-1990	29 (42.03)	18.7374
1990's	15 (21.74)	18.2507
2000's	13 (18.84)	29.6817
2010's	12 (17.39)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bañuelos-Ávila, AJ; Barrera-Chairez, E; Fernandez-Vargas, OE; Ron-Guerrero, CS; Ron-Magaña, AL	1
Billett, AL; Dahmoush, HM; Grant, FD; LaCasce, AS; Lehmann, LE; Margossian, SP; Ozuah, NW	1
Abounader, D; Andritsos, L; Benson, DM; Bolwell, B; Dean, R; Devine, SM; Efebera, YA; Elder, P; Hill, B; Hofmeister, CC; Jagadeesh, D; Jaglowski, S; Kalaycio, M; Majhail, NS; Penza, S; Pohlman, B; Rosko, A; Sharma, N; Singer, S; Sobecks, R; Vasu, S; William, BM; Zhao, Q	1
Diepstra, A; Liang, Z; Plattel, W; Van Den Berg, A; van Imhoff, G; Visser, L; Xu, C	1
Abela, EM; Anagnostopoulos, A; Apostolou, C; Baliakas, P; Batsis, I; Douka, V; Iskas, M; Kaloyannidis, P; Karypidis, K; Konstantinou, V; Kouvatseas, G; Mallouri, D; Marvaki, A; Sakellari, I; Smias, C; Sotiropoulos, D; Yannaki, E	1
Chwieduk, A; Fidyk, W; Giebel, S; Głowala-Kosińska, M; Mitrus, I; Najda, J; Smagur, A	1
Christofides, A; Isidori, A; Visani, G	1
Ammari, S; Canova, C; Dercle, L; Deutsch, E; Levy, A; Marabelle, A; Mazeron, R; Michot, JM; Ribrag, V; Rose, S; Rubin, E; Soria, JC	1
Bouabdallah, K; Cornillon, J; Damaj, G; Gastinne, T; Ghésquières, H; Gressin, R; Gyan, E; Ranchon, F; Salles, G; Vigouroux, S; Yakoub-Agha, I	1
Cornely, OA; Keulertz, C; Lövenich, H; Rüping, MJ; Söhngen, D; Vehreschild, JJ; Wieland, U	1
Buset, EM; Haile, SR; Honegger, H; Knuth, A; Mischo, A; Pestalozzi, BC; Petrausch, U; Renner, C; Samaras, P; Schanz, U; Siciliano, RD; Stahel, RA; Stenner-Liewen, F; Stussi, G	1
Bruno, A; Cantoni, F; Cupelli, L; Datturi, T; De Angelis, V; de Fabritiis, P; De Meis, I; Dentamaro, T; Niscola, P; Tendas, A	1
Carella, A; de Elvira, CR; Goldstone, AH; Mackinnon, S; Robinson, SP; Russell, N; Schmitz, N; Taghipour, G	1
Aleĭnikova, OV; Pochetukhin, KV; Strongin, IuS	1
Grøttum, P; Kvalheim, G; Rusten, LS; Østby, I	1
Belford, D; Gates, P; Jablonskis, L; Januszewicz, H; Lillie, K; Prince, HM; Regester, G; Seymour, JF; West, R; Wolf, M	1
Albarello, A; Ballerini, F; Balocco, M; Canepa, L; Canepa, P; Clavio, M; Garrone, A; Gobbi, M; Michelis, GL; Miglino, M; Pierri, I; Varaldo, R	1
Bakshi, A; Bhagwat, R; Biswas, G; Khadwal, A; Narayanan, P; Parikh, P; Sastry, P	1
Gisselbrecht, C; Hagberg, H	1
Balzarotti, M; Bramanti, S; Castagna, L; Magagnoli, M; Mazza, R; Nozza, A; Russo, F; Santoro, A; Sarina, B; Siracusano, L; Timofeeva, I; Todisco, E	1
Blundell, E; Goldstone, AH; Linch, DC; Peggs, KS; Thomson, KJ	1
Abdelsalam, M; Akhtar, S; El Weshi, A; Hussaini, H; Janabi, I; Maghfoor, I; Rahal, M	1
Carbone, A; Franchin, G; Galligioni, E; Grigoletto, E; Tirelli, U; Trovo, MG; Tumolo, S; Veronesi, A; Volpe, R	1
Dombernowsky, P; Hansen, HH; Nissen, NI; Pedersen, AG	1
Kondrat'eva, NA; Maiakova, SA; Makhonova, LA; Vialushkin, BIa	1
Gershanovich, ML; Kondrat'ev, VB; Kondrat'eva, NA; Lebedev, VN; Vialushkin, VIa	1
Gershanovich, ML; Kondrat'ev, VB; Kondrat'eva, NA; Lebedev, VN; Vygovskaia, IaI	1
Chatterjee, R; Goldstone, AH; Katz, M; McGarrigle, HH; Mills, W	1
Phillips, GL; Reece, DE	1
Brandwein, JM; Colwill, R; Couture, F; Crump, M; Danish, R; Keating, A; Scott, JG; Stewart, AK; Sutcliffe, SB; Sutton, DM	1
Brice, P; Castaigne, S; Gisselbrecht, C; Marolleau, JP; Pautier, P	1
Barge, A; Boogaerts, MA; Demuynck, HM; Dreger, P; Ferrant, A; Goldstone, AH; Linch, DC; Link, H; Schmitz, N; Zander, A	1
Billingham, LJ; Knechtli, CJ; Long, SG; Lumley, MA; McDonald, DF; Milligan, DW	1
Batan, ZE; Milanovich, NF; Skriagin, AE; Snegir', VM; Uss, AL; Zmachinskiĭ, VA	1
Caballero, MD; Corral, M; del Cañizo, MC; García-Sanz, R; Gonzalez, M; Heras, I; Jean-Paul, E; León, A; Moraleda, JM; Rifon, J; Rocha, E; Rubio, V; San Miguel, JF; Vázquez, L; Vidriales, B	1
Geisler, C; Myhre, J; Pedersen, M; Pedersen-Bjergaard, J	1
Caballero, D; del Cañizo, C; García-Sanz, R; González, M; Heras, I; Jean-Paul, E; León, A; Pérez-Simón, JA; Rifon, J; Rocha, E; Rubio, V; San Miguel, JF; Vicente, V; Vidriales, B	1
Cooper, DL; D'Andrea, E; Hu, GL; Jillella, AP; Nadkarni, R; Salloum, E; Seropian, S; Zelterman, D	1
Burtness, B; Cooper, DL; Hu, GL; Jillella, AP; Nadkarni, R; Salloum, E; Seropian, S; Zelterman, D	1
Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D	1
Aguado, MJ; Canales, MA; de Bustos, JG; Fernández-Jiménez, MC; Hernández-Navarro, F; Ojeda, E	1
Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O	1
Caballero, MD; Canales, MA; Fernández-Jiménez, MC; García de Bustos, J; Hernández-Navarro, F; Martín, A; Pérez-Simón, JA; San Miguel, JF; Vázquez, L	1
Becherer, A; Dudczak, R; Greinix, HT; Jaeger, U; Kalhs, P; Karanikas, G; Kletter, K; Mitterbauer, M; Pötzi, C; Raderer, M	1
Charron, D; Dumonchel, P; Jorry, F; Laurens, A; Martola, R; Thevenot, J	1
Begg, CB; Bennett, JM; Brodovsky, HS; Carbone, PP; Chiuten, DF; Creech, RH; Falkson, G; Glick, J; Muggia, FM	1
Al-Sarraf, M; Cecil, JW; Coltman, CA; Groppe, CW; Quagliana, JM; Thigpen, T	1
Carter, SK; Livingston, RB	1
Bodrogi, I; Döbrentey, E; Eckhardt, S	1
Adam, M; Baruchel, A; Brice, P; Dombret, H; Gisselbrecht, C; Lepage, E; Marolleau, JP; Miclea, JM; Sitthy, X	1
McVie, G; Muggia, FM	1
Alonso, MT; Leyland-Jones, B; Marsoni, S; O'Dwyer, PJ; Wittes, RE	1
Cummings, J; Cunningham, D; Forrest, GJ; McTaggart, L; Soukop, M; Stuart, JF	1
Anderson, CC; Cawley, JC; Goldstone, AH; Harper, PG; Jelliffe, AM; Jones, M; Linch, DC; Machin, SJ; McLennan, KA; Souhami, RL	1
Háber, J; Klener, P	1
Amiel, JL; Mathé, G	1
Amiel, JL; Céoara, B; de Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Oldham, R; Pouillart, P; Rosenfeld, C; Schneider, M; Schwarzenberg, L; Steresco-Musset, M; Weiner, R	1
Amiel, JL; Céoara, B; de Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Oldham, R; Pouillart, P; Schneider, M; Schwarzenberg, L; Steresco-Musset, M; Weiner, R	1
Amiel, JL; De Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Misset, JL; Musset, M; Oldham, R; Pouillart, P; Rosenfeld, C; Schneider, M; Schwarzenberg, L; Weiner, R	1
Carter, SK; Goldsmith, MA	1
Alberto, P; Giger, K; Nagel, G; Senn, HJ; Sonntag, RW	1
Larsen, V; Nissen, NI; Pedersen, H; Thomsen, K	1
DOGLIOTTI, GC	1
Amiel, JL; Beyer, HP; de Vassal, F; Fajbisowicz, S; Hayat, M; Jasmin, C; Mathé, G; Pouillart, P; Schneider, M; Schwarzenberg, L; Weiner, R	1
Dombernowsky, P; Larsen, V; Nissen, NI	1
Halama, J	1
Clément, F	1

Reviews

7 review(s) available for podophyllotoxin and Hodgkin Disease

Article	Year
Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning. Leukemia & lymphoma, 2016, Volume: 57, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Melphalan; Podophyllotoxin; Recurrence; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome	2016
Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review. Bone marrow transplantation, 2017, Volume: 52, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Cytarabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Melphalan; Podophyllotoxin	2017
The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a review. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1980, Volume: 74 Topics: Animals; Antineoplastic Agents; Etoposide; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lung Neoplasms; Podophyllotoxin; Teniposide	1980
Intensive therapy and autotransplantation in Hodgkin's disease. Stem cells (Dayton, Ohio), 1994, Volume: 12, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Digestive System Diseases; Etoposide; Heart Diseases; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lung Diseases; Melphalan; Multicenter Studies as Topic; Podophyllotoxin; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome; Whole-Body Irradiation	1994
Plant products in cancer chemotherapy. Cancer treatment reports, 1976, Volume: 60, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Hodgkin Disease; Humans; Lymphoma; Neoplasms; Phytotherapy; Plants, Medicinal; Podophyllotoxin; Vinblastine; Vinca Alkaloids; Vincristine	1976
Etoposide (VP-16-213). Current status of an active anticancer drug. The New England journal of medicine, 1985, Mar-14, Volume: 312, Issue:11 Topics: Animals; Carcinoma, Small Cell; Clinical Trials as Topic; DNA; Drug Administration Schedule; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Male; Mice; Podophyllotoxin; Testicular Neoplasms; Tissue Distribution	1985
4'-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside (VM-26)--a brief review. European journal of cancer, 1973, Volume: 9, Issue:7 Topics: Alopecia; Animals; Brain Neoplasms; Clinical Trials as Topic; DNA; Glycosides; Hodgkin Disease; Humans; Hypotension; Leukopenia; Mitosis; Neoplasms, Experimental; Podophyllotoxin; Solubility; Structure-Activity Relationship; Thiophenes; Urinary Bladder Neoplasms	1973

Trials

18 trial(s) available for podophyllotoxin and Hodgkin Disease

Article	Year
Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation. Pediatric blood & cancer, 2018, Volume: 65, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Child; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Melphalan; Podophyllotoxin; Positron-Emission Tomography; Preoperative Care; Retrospective Studies; Stem Cell Transplantation; Survival Rate	2018
Trial of amifostine in autologous stem cell transplant. Bone marrow transplantation, 2006, Volume: 37, Issue:1 Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Cytarabine; Female; Graft Survival; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Podophyllotoxin; Radiation-Protective Agents; Stem Cell Transplantation; Transplantation, Homologous	2006
Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17 Suppl 4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome	2006
[Results of a clinical study of an epipodophyllotoxin preparation (VM 26) in children with hemoblastoses]. Problemy gematologii i perelivaniia krovi, 1981, Volume: 26, Issue:4 Topics: Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Podophyllotoxin; Prednisolone; Teniposide; Time Factors	1981
[Use of preparation VM 26 (epipodophyllotoxin) for treating lymphomas in children and adults]. Voprosy onkologii, 1981, Volume: 27, Issue:4 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Hodgkin Disease; Humans; Infant; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Podophyllotoxin; Teniposide; Time Factors	1981
Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Confidence Intervals; Critical Care; Cytarabine; Erythrocyte Transfusion; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Neutropenia; Platelet Transfusion; Podophyllotoxin; Preoperative Care; Prognosis; Recurrence; Salvage Therapy; Time Factors	1995
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet (London, England), 1996, Feb-10, Volume: 347, Issue:8998 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukocytes, Mononuclear; Lymphoma, Non-Hodgkin; Male; Melphalan; Platelet Transfusion; Podophyllotoxin; Prospective Studies; Recombinant Proteins; Survival Analysis; Time Factors; Transplantation, Autologous	1996
High lactate dehydrogenase level is associated with an adverse outlook in autografting for Hodgkin's disease. Bone marrow transplantation, 1996, Volume: 17, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; L-Lactate Dehydrogenase; Male; Melphalan; Middle Aged; Podophyllotoxin; Prognosis; Recurrence; Survival Rate; Transplantation, Autologous; Treatment Outcome	1996
High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure. Leukemia, 1997, Volume: 11, Issue:10 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Risk Factors	1997
Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantation. Haematologica, 1999, Volume: 84, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carmustine; Cytarabine; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Podophyllotoxin; Recurrence; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome	1999
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474). Cancer treatment reports, 1979, Volume: 63, Issue:1 Topics: Adult; Aged; Blood Cell Count; Clinical Trials as Topic; Drug Evaluation; Female; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Podophyllotoxin; Teniposide	1979
Results obtained with combination therapy of VM-26, natulan and prednisolone in generalized Hodgkin's disease. Chemotherapy, 1975, Volume: 21, Issue:3-4 Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Aged; Podophyllotoxin; Prednisolone; Procarbazine; Radiography; Teniposide; Time Factors	1975
Etoposide (VP-16-213). Current status of an active anticancer drug. The New England journal of medicine, 1985, Mar-14, Volume: 312, Issue:11 Topics: Animals; Carcinoma, Small Cell; Clinical Trials as Topic; DNA; Drug Administration Schedule; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Male; Mice; Podophyllotoxin; Testicular Neoplasms; Tissue Distribution	1985
Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours. British medical journal, 1973, Jul-28, Volume: 3, Issue:5873 Topics: Adult; Aged; Agranulocytosis; Alopecia; Antineoplastic Agents; Female; Glycosides; Hodgkin Disease; Humans; Lactones; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nausea; Neoplasms; Neutrophils; Podophyllotoxin; Remission, Spontaneous; Thrombocytopenia; Vomiting	1973
Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas. Cancer, 1974, Volume: 34, Issue:4 Topics: Adolescent; Adult; Aged; Alopecia; Child; Child, Preschool; Clinical Trials as Topic; Digestive System; Drug Evaluation; Female; Glycosides; Hodgkin Disease; Humans; Injections, Intravenous; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukopenia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pleural Effusion; Podophyllotoxin; Thrombocytopenia	1974
4'-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside (VM-26)--a brief review. European journal of cancer, 1973, Volume: 9, Issue:7 Topics: Alopecia; Animals; Brain Neoplasms; Clinical Trials as Topic; DNA; Glycosides; Hodgkin Disease; Humans; Hypotension; Leukopenia; Mitosis; Neoplasms, Experimental; Podophyllotoxin; Solubility; Structure-Activity Relationship; Thiophenes; Urinary Bladder Neoplasms	1973
Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213). Cancer chemotherapy reports, 1972, Volume: 56, Issue:6 Topics: Animals; Cells, Cultured; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Glycosides; Haplorhini; Hemoglobins; Hodgkin Disease; Humans; Lethal Dose 50; Macaca; Mice; Neoplasm Transplantation; Neoplasms; Podophyllotoxin; Remission, Spontaneous; Solubility; Time Factors; Transplantation, Homologous	1972
Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours. British medical journal, 1972, Jun-24, Volume: 2, Issue:5816 Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Anemia, Aplastic; Antineoplastic Agents; Blood Platelet Disorders; Child; Clinical Trials as Topic; Female; Gastrointestinal Diseases; Glycosides; Hematopoiesis; Hodgkin Disease; Humans; Lactones; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Remission, Spontaneous; Thiophenes; Urinary Bladder Neoplasms	1972

Other Studies

46 other study(ies) available for podophyllotoxin and Hodgkin Disease

Article	Year
BEAM-Modified Conditioning Therapy with Cisplatin+Dexamethasone Instead of Carmustine Prior to Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma. Annals of transplantation, 2019, Oct-22, Volume: 24 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Podophyllotoxin; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Young Adult	2019
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Podophyllotoxin; Transplantation Conditioning; Young Adult	2019
Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma. PloS one, 2014, Volume: 9, Issue:1 Topics: Cell Line, Tumor; Cell Proliferation; Hodgkin Disease; Humans; Podophyllotoxin; Prognosis; Receptor, IGF Type 1; Survival Analysis; Tumor Microenvironment	2014
Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgk Leukemia & lymphoma, 2015, Volume: 56, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Matched-Pair Analysis; Melphalan; Middle Aged; Neoplasm Staging; Podophyllotoxin; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult	2015
Thymic Activity and T Cell Repertoire Recovery after Autologous Hematopoietic Stem Cell Transplantation Preceded by Myeloablative Radiotherapy or Chemotherapy. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Cyclophosphamide; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Podophyllotoxin; Thymus Gland; Transplantation Conditioning; Whole-Body Irradiation	2016
Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody. European journal of cancer (Oxford, England : 1990), 2016, Volume: 66 Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Hodgkin Disease; Humans; Male; Melphalan; Neoplasm Metastasis; Podophyllotoxin; Programmed Cell Death 1 Receptor; Remission Induction; Salvage Therapy	2016
Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Cytokines; Female; Herpesvirus 1, Human; Herpesvirus 2, Human; Hodgkin Disease; Humans; Inflammation; Interleukin-1; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Podophyllotoxin; Saliva; Severity of Illness Index; Statistics as Topic; Stem Cell Transplantation; Stomatitis; Transplantation, Autologous; Tumor Necrosis Factor-alpha; Young Adult	2011
Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation. Oncology, 2010, Volume: 79, Issue:1-2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Length of Stay; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Polyethylene Glycols; Recombinant Proteins; Severity of Illness Index; Thrombocytopenia; Time Factors; Transplantation, Autologous; Treatment Outcome; Young Adult	2010
Single-dose pegylated-filgrastim versus daily filgrastim after high-dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies: delayed platelets recovery? Blood transfusion = Trasfusione del sangue, 2012, Volume: 10, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Carmustine; Cytarabine; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Platelet Count; Podophyllotoxin; Polyethylene Glycols; Recombinant Proteins; Recovery of Function; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous	2012
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. Blood, 2002, Dec-15, Volume: 100, Issue:13 Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cohort Studies; Cytarabine; Disease Progression; Drug Resistance, Neoplasm; Europe; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hodgkin Disease; Humans; Immunosuppressive Agents; Life Tables; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Proportional Hazards Models; Salvage Therapy; Survival Analysis; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine	2002
[High-dose chemotherapy with autologous bone marrow transplantation in children with high-risk malignant neoformations]. Voprosy onkologii, 2002, Volume: 48, Issue:3 Topics: Adolescent; Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carboplatin; Carmustine; Child; Child, Preschool; Cytarabine; Dacarbazine; Data Interpretation, Statistical; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Melphalan; Podophyllotoxin; Rhabdomyosarcoma; Sarcoma, Ewing; Sex Factors; Statistics, Nonparametric; Time Factors; Transplantation, Autologous; Vinblastine	2002
A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation. Journal of mathematical biology, 2003, Volume: 47, Issue:2 Topics: Adult; Algorithms; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Differentiation; Cell Division; Computer Simulation; Cytarabine; Dose-Response Relationship, Drug; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Kinetics; Leukocytes, Mononuclear; Lymphoma, Non-Hodgkin; Melphalan; Middle Aged; Models, Biological; Myelopoiesis; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Transplantation, Autologous	2003
A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapy. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2005, Volume: 11, Issue:7 Topics: Adult; Aged; Animals; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cattle; Complex Mixtures; Cytarabine; Dose-Response Relationship, Drug; Female; Growth Substances; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Milk; Mouth Mucosa; Mouthwashes; Podophyllotoxin; Stomatitis	2005
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies. Oncology reports, 2005, Volume: 14, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mitoxantrone; Multiple Myeloma; Odds Ratio; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Recurrence; Remission Induction; Salvage Therapy; Time Factors; Transplantation Conditioning; Treatment Outcome	2005
Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study. American journal of hematology, 2007, Volume: 82, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Prospective Studies; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous; Vinblastine; Vinorelbine	2007
A second autologous transplant may be efficacious in selected patients with Hodgkin's lymphoma relapsing after a previous autograft. Leukemia & lymphoma, 2007, Volume: 48, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Follow-Up Studies; Graft Survival; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Podophyllotoxin; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous	2007
Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients. Bone marrow transplantation, 2007, Volume: 40, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Cohort Studies; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Multivariate Analysis; Neoplasm Staging; Podophyllotoxin; Prognosis; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Survival Analysis; Treatment Outcome	2007
VM26 in malignant hematological diseases. A phase II study. Cancer chemotherapy and pharmacology, 1982, Volume: 7, Issue:2-3 Topics: Drug Evaluation; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma; Multiple Myeloma; Podophyllotoxin; Teniposide	1982
[Use of VM 26 (epipodophyllotoxin) in treating acute leukemias and lymphomas in the adult]. Problemy gematologii i perelivaniia krovi, 1981, Volume: 26, Issue:7 Topics: Acute Disease; Adult; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Lymphoma; Podophyllotoxin; Teniposide; Time Factors	1981
Induction of ovarian function by using short-term human menopausal gonadotrophin in patients with ovarian failure following cytotoxic chemotherapy for haematological malignancy. Leukemia & lymphoma, 1993, Volume: 10, Issue:4-5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Leukemia, Myelomonocytic, Acute; Luteinizing Hormone; Melphalan; Menotropins; Ovulation Induction; Podophyllotoxin; Prednisone; Pregnancy; Pregnancy, Multiple; Primary Ovarian Insufficiency; Remission Induction; Teniposide; Thioguanine; Vincristine	1993
Pregnancy after autologous bone marrow transplantation for malignant lymphomas. Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infant, Newborn; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Melphalan; Podophyllotoxin; Prednisone; Pregnancy; Pregnancy Outcome; Procarbazine; Remission Induction; Salvage Therapy; Vincristine	1994
[Hemopoietic stem cell transplantation in lymphogranulomatosis]. Voprosy onkologii, 1997, Volume: 43, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Carmustine; Child; Cytarabine; Female; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Length of Stay; Male; Melphalan; Podophyllotoxin; Recurrence; Treatment Outcome	1997
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone marrow transplantation, 1997, Volume: 20, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Cytarabine; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Podophyllotoxin; Prognosis; Treatment Outcome	1997
[Autologous transplant with BEAM protocol in lymphoma]. Sangre, 1997, Volume: 42 Suppl 1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Podophyllotoxin; Prognosis; Remission Induction; Transplantation Conditioning; Transplantation, Autologous	1997
Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor cell transplantation. Cancer, 1998, Apr-15, Volume: 82, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Female; Heart; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lung; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neutropenia; Neutrophils; Podophyllotoxin; Respiratory Function Tests; Retrospective Studies; Ventricular Function, Left	1998
Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option. Bone marrow transplantation, 1999, Volume: 23, Issue:6 Topics: Adult; Ambulatory Care; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dose-Response Relationship, Drug; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Melphalan; Middle Aged; Neutropenia; Podophyllotoxin; Retrospective Studies	1999
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. British journal of cancer, 1999, Volume: 81, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine	1999
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer]. Harefuah, 2000, Volume: 139, Issue:5-6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cytarabine; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Survival Rate; Time Factors; Vinblastine; Vincristine	2000
Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease. British journal of haematology, 2001, Volume: 113, Issue:1 Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Carmustine; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Podophyllotoxin; Prognosis; Recurrence; Salvage Therapy; Sex Factors; Survival Analysis; Transplantation, Autologous	2001
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia, 2002, Volume: 16, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prognosis; Radiopharmaceuticals; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation	2002
[Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas]. Annales de medecine interne, 1977, Volume: 128, Issue:5 Topics: Adolescent; Adult; Aged; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Prednisone; Teniposide	1977
Evaluation of VP-16-213 in malignant lymphoma and melanoma. Cancer treatment reports, 1978, Volume: 62, Issue:5 Topics: Adult; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma; Male; Melanoma; Podophyllotoxin	1978
Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas. Bone marrow transplantation, 1992, Volume: 9, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion, Autologous; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Podophyllotoxin; Salvage Therapy; Whole-Body Irradiation	1992
Treatment strategies in relation to drug action. NCI monographs : a publication of the National Cancer Institute, 1987, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; DNA Topoisomerases, Type II; Etoposide; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Podophyllotoxin; Teniposide	1987
Etoposide: a pharmacokinetic profile including an assessment of bioavailability. Medical oncology and tumor pharmacotherapy, 1986, Volume: 3, Issue:2 Topics: Administration, Oral; Biological Availability; Carcinoma; Carcinoma, Small Cell; Etoposide; Female; Hodgkin Disease; Humans; Injections, Intravenous; Kinetics; Lung Neoplasms; Lymphoma; Male; Neoplasms; Podophyllotoxin	1986
Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphoma. Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Female; Hodgkin Disease; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin	1986
[Etoposide in the treatment of recurrent malignant lymphoma]. Vnitrni lekarstvi, 1986, Volume: 32, Issue:4 Topics: Adolescent; Adult; Aged; Etoposide; Hodgkin Disease; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin	1986
[Chemotherapy of Hodgkin's disease]. La Revue du praticien, 1974, Oct-11, Volume: 24, Issue:45 Topics: Antineoplastic Agents; Bleomycin; Drug Hypersensitivity; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Podophyllotoxin; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine	1974
[Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)]. La Nouvelle presse medicale, 1974, Mar-02, Volume: 3, Issue:9 Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Child; Child, Preschool; Female; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lymphatic Diseases; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Thrombocytopenia	1974
[Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)]. La Nouvelle presse medicale, 1974, Feb-23, Volume: 3, Issue:8 Topics: Adolescent; Adult; Aged; Female; Hodgkin Disease; Humans; Leukemia, Myeloid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous	1974
Experience with 4'-demethylepipodo-phyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis. European journal of cancer, 1974, Volume: 10, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Blood Platelet Disorders; Dose-Response Relationship, Drug; Female; Glucosides; Glycosides; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous; Thiophenes	1974
[EARLY DIAGNOSIS AND MEDICAL THERAPY OF MALIGNANT TUMORS]. Il Cancro, 1963, Volume: 16 Topics: Antineoplastic Agents; Busulfan; Colchicine; Early Diagnosis; Hodgkin Disease; Mechlorethamine; Mercaptopurine; Neoplasms; Phenylalanine; Podophyllum; Triethylenemelamine; Vinblastine	1963
[Clinical trial of chemotherapeutic combinations based on the notion of attempted cellular synchronization. Preliminary administration of an antimitotic followed by the use of cycle-dependent or phase dependent product(s)]. La Nouvelle presse medicale, 1972, Jun-24, Volume: 1, Issue:26 Topics: Amino Sugars; Anthraquinones; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Daunorubicin; DNA; Drug Combinations; Drug Tolerance; Female; Hodgkin Disease; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mitosis; Neoplasm Metastasis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Prednisone; Prognosis; Time Factors	1972
Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors. Cancer chemotherapy reports, 1972, Volume: 56, Issue:1 Topics: Adult; Aged; Animals; Antineoplastic Agents; Female; Glycosides; Haplorhini; Hodgkin Disease; Humans; Immunosuppression Therapy; Lactones; Lymphoma; Male; Mice; Middle Aged; Neoplasms; Neoplasms, Experimental; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Rats; Thiophenes	1972
[Experiences with the cytostatic podophyllin therapy]. Munchener medizinische Wochenschrift (1950), 1967, Feb-18, Volume: 108, Issue:7 Topics: Adult; Aged; Breast Neoplasms; Bronchial Neoplasms; Female; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Neoplasm Metastasis; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Testicular Neoplasms	1967
[The chemotherapy of cancer]. Praxis, 1967, Dec-07, Volume: 56, Issue:49 Topics: Adult; Alkylating Agents; Antimetabolites; Antineoplastic Agents; Dactinomycin; Female; Fluorouracil; Hodgkin Disease; Humans; Lung Neoplasms; Male; Melphalan; Methotrexate; Middle Aged; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Radiography; Sarcoma, Ewing; Thiotepa; Vincristine	1967